LMAT - CIK 0001158895
The table below shows LEMAITRE VASCULAR INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $81.25M | $44.12M | $36.75M | $25.38M | $35.10M | $34.80M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | -$64.94M | -$200.12M | -$24.71M | -$10.37M | -$61.08M | -$52.89M |
| Dividends paid | $18.11M | $14.38M | $12.45M | $10.99M | $9.34M | $7.70M |
LEMAITRE VASCULAR INC reported operating cash flow of $81.25M for fiscal year 2025. That is up 84.1% from $44.12M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $16.90M (FY 2016) to $81.25M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | $1.82M | $1.72M | $853.00K | $642.00K | $802.00K | $570.00K |
| Financing cash flow | -$14.54M | $158.10M | -$7.13M | -$9.23M | $13.70M | $32.16M |